Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1985 1
1986 3
1987 1
1988 1
1989 6
1990 6
1991 9
1992 10
1993 14
1994 21
1995 19
1996 24
1997 24
1998 18
1999 15
2000 16
2001 14
2002 15
2003 15
2004 29
2005 23
2006 20
2007 23
2008 12
2009 18
2010 10
2011 3
2012 4
2013 6
2014 5
2015 2
2016 3
2018 1
2019 3
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 9-tetrahydro-1H-b-carboline
Page 1
Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R, Khan S, Verma A, Srivastava S, Viswakarma P, Gupta S, Meena S, Singh N, Sarkar J, Chauhan PM. Kumar R, et al. Eur J Med Chem. 2010 Aug;45(8):3274-80. doi: 10.1016/j.ejmech.2010.04.004. Epub 2010 Apr 14. Eur J Med Chem. 2010. PMID: 20457476
A series of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carboline derivatives has been synthesized and evaluated for antileishmanial activity against Leishmania donovani. ...
A series of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carboline derivatives has been synthes …
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
Minor DL, Wyrick SD, Charifson PS, Watts VJ, Nichols DE, Mailman RB. Minor DL, et al. J Med Chem. 1994 Dec 9;37(25):4317-28. doi: 10.1021/jm00051a008. J Med Chem. 1994. PMID: 7996543
New 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro- 13bH-dibenzo[a,h]-quinolizines were prepared as ring-contracted analogs of the prototypical 1-phenyl-2,3,4,5-tetrahydrobenzazepines (e.g., SCH23390) as a continuation o …
New 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro- 13bH-dibenzo[a,h]-quinolizines were prepared as ring-contracted …
Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
Katagiri N, Abe K, Kitabatake M, Utsunomiya I, Horiguchi Y, Hoshi K, Taguchi K. Katagiri N, et al. Neuroscience. 2009 Jun 2;160(4):820-8. doi: 10.1016/j.neuroscience.2009.03.009. Epub 2009 Mar 12. Neuroscience. 2009. PMID: 19285542
This 1-BnTIQ-induced locomotor activity was attenuated by pre-treatment with SCH23390 (R(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochlodride) and raclopride, D(1) and D(2) dopaminergic receptor antagonists, …
This 1-BnTIQ-induced locomotor activity was attenuated by pre-treatment with SCH23390 (R(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl …
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
Pfeiffer FR, Wilson JW, Weinstock J, Kuo GY, Chambers PA, Holden KG, Hahn RA, Wardell JR Jr, Tobia AJ, Setler PE, Sarau HM. Pfeiffer FR, et al. J Med Chem. 1982 Apr;25(4):352-8. doi: 10.1021/jm00346a005. J Med Chem. 1982. PMID: 7069713
6-Chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines were synthesized and evaluated as agonists of central and peripheral dopamine receptors. ...
6-Chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines were synthesized and evaluated as ag …
Participation of D 1-4 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV.
Braszko JJ. Braszko JJ. Neurosci Biobehav Rev. 2010 Mar;34(3):343-50. doi: 10.1016/j.neubiorev.2009.08.001. Epub 2009 Aug 15. Neurosci Biobehav Rev. 2010. PMID: 19686774 Review.
Recent studies demonstrated that the improvement of several memory aspects; recall of appetitively and aversively motivated behaviors and learning of spatial tasks by Ang IV and des-Phe(6)Ang IV was abolished, or significantly diminished by behaviorally inactive per se doses of t …
Recent studies demonstrated that the improvement of several memory aspects; recall of appetitively and aversively motivated behaviors and le …
Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
Domino EF, Ni L. Domino EF, et al. J Pharmacol Exp Ther. 1998 Jan;284(1):307-11. J Pharmacol Exp Ther. 1998. PMID: 9435192
Trihexyphenidyl was then studied in combination with the selective dopamine receptor D1 agonist SKF-82958 [(+/-)-6-chloro-7-8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro- 1H-benzazepine hydrobromide] and the selective D2 agonist N-0923 [(-)2-( …
Trihexyphenidyl was then studied in combination with the selective dopamine receptor D1 agonist SKF-82958 [(+/-)-6-chloro-7-8-dihydroxy-3-al …
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
Charifson PS, Wyrick SD, Hoffman AJ, Simmons RM, Bowen JP, McDougald DL, Mailman RB. Charifson PS, et al. J Med Chem. 1988 Oct;31(10):1941-6. doi: 10.1021/jm00118a012. J Med Chem. 1988. PMID: 3050089
A series of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines have been prepared as ring-contracted analogues of the prototypical D1 dopamine receptor antagonist SCH23390 [(R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tet …
A series of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines have been prepared as ring-contracted analogues of the protot …
Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
Noda Y, Kurumiya S, Miura Y, Oka M. Noda Y, et al. J Pharmacol Exp Ther. 1993 May;265(2):745-51. J Pharmacol Exp Ther. 1993. PMID: 8098763
In rats treated for 21 days with haloperidol (3 mg/kg, once a day p.o.) and (+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzaze pine [(+)SCH23390] (0.05 mg/kg, twice a day s.c.), but not with AD-5423 (10 mg/kg, once a day p. …
In rats treated for 21 days with haloperidol (3 mg/kg, once a day p.o.) and (+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2, …
371 results